Drug Database
Back to search

Switzerland· 41958030

Corvaton Forte

A molsidomine product containing molsidominum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 8 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC C01DX12

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedCorvaton ForteATCC01DX12REGISTER NO.41958030PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about molsidominumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Molsidomine is registered in 8 of 19 countries.

Countries holding a registration under ATC C01DX12 (molsidomine), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 6 of them publish a price we can compare per daily dose
Search molsidomine products by name

Molsidomine · ATC C01DX12

8 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Franceprice
  • Germany
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of molsidomine costs, country by country.

Normalised to the WHO defined daily dose (8 mg), the median price runs from $0.33 in France to $0.63 in Switzerland — a ×1.9 gap.

  • Switzerland: $0.63 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Molsidomine · price per daily dose (8 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.63
  • FR France$0.33
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
molsidominum
Manufacturer
—
Country
Switzerland (CH)
ATC code
C01DX12
ATC class
Molsidomine
Defined daily dose
8 mg, O
Swissmedic category
B
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680419580305
    30 Stk
    CHF 12.2

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

5 interactions on record for molsidomine.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check molsidomine against other medicinesHow interaction checks work

Molsidomine · interactions on record

5 records

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Molsidomine in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All molsidomine products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Molsidolat
  • Belgium · Coruno, Corvaton
  • Bulgaria · Молсидомин Wzf, Сиднофарм
  • Czechia · Corvaton Forte
  • Germany · Corvaton, Corvaton Forte
  • Spain · Molsidain
  • France · Corvasal, Molsidomine Arrow
  • Hungary · Corvaton, Corvaton Forte
  • Lithuania · Molsidominum Pph
  • Luxembourg · Coruno, Corvaton
  • Poland · Molsidomina Wzf
  • Slovakia · Corvaton, Corvaton Forte

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/13b0c1e3-a243-4ca6-80e2-941063eae781
GET /v1/drugs/13b0c1e3-a243-4ca6-80e2-941063eae781?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "molsidominum 4 mg",
  "valid_from": "1985-03-15",
  "limitations": null,
  "galenic_form": "Tabl 4 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "1985-03-15",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about molsidomine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console